SIGNALAI·May 28, 2026, 4:00 AMSignal75Short term

StoryMI: Steerable Multi-Agent Therapeutic Dialogue Generation

Source: arXiv cs.AI

Share
StoryMI: Steerable Multi-Agent Therapeutic Dialogue Generation

arXiv:2605.27393v1 Announce Type: cross Abstract: Large language models (LLMs) can generate fluent dialogue, but prior works lack situational grounding, dynamic strategy control, and evaluation aligned with clinical standards in motivational interviewing (MI). We introduce StoryMI, a multi-LLM agent framework for controllable MI dialogue generation, where questionnaire-based client profiles are expanded into situational stories that provide narrative context for the dialogue. Therapist and client agents generate MI-coded utterances guided by MI codes selected by the interaction agent, while an

Why this matters
Why now

The rapid advancement of large language models (LLMs) is enabling increasingly sophisticated applications in specialized domains like therapeutic dialogue, previously considered too nuanced for AI.

Why it’s important

This development indicates a significant step towards autonomous AI systems capable of handling complex, sensitive human interactions, potentially transforming professional services and mental health support.

What changes

AI is moving beyond simple conversational agents to multi-agent frameworks that can dynamically adapt strategies and ground dialogues in specific situational contexts, mirroring human therapeutic approaches.

Winners
  • · Mental health tech companies
  • · Healthcare providers
  • · AI platform developers
  • · Patients seeking accessible therapy
Losers
  • · Traditional therapy models reliant solely on human interaction
  • · Companies offering rudimentary chatbot solutions
Second-order effects
Direct

Therapeutic dialogues become more scalable and accessible through AI-driven platforms.

Second

The integration of AI agents could lead to new models of care, blending human oversight with AI delivery, affecting workforce structures in healthcare.

Third

Ethical and regulatory frameworks will need to rapidly evolve to govern autonomous therapeutic AI, addressing issues of responsibility, bias, and patient safety.

Editorial confidence: 90 / 100 · Structural impact: 60 / 100
Original report

This signal links to a primary source. Continuum Brief monitors and indexes it as part of the live intelligence stream — we do not republish source content.

Read at arXiv cs.AI
Tracked by The Continuum Brief · live intelligence network
Share
The Brief · Weekly Dispatch

Stay ahead of the systems reshaping markets.

By subscribing, you agree to receive updates from THE CONTINUUM BRIEF. You can unsubscribe at any time.